1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Caring for Caregivers" is currently closed and not accepting applications.
Caring for Caregivers is sponsored by Tennessee Department of Disability and Aging (DDA) / Area Agencies on Aging and Disability (AAAD). This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Family caregivers of eligible family members. Specific eligibility information is available through local Area Agencies on Aging and Disability (AAADs). Confirm the full requirements in the official notice before applying.
The published deadline was August 7, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Caring for Caregivers is funded by Tennessee Department of Disability and Aging (DDA) / Area Agencies on Aging and Disability (AAAD). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Tennessee's $206.9M RHTP allocation begins distribution with a 30-day virtual maternal/child mental health consultation grant. The state plans a new opportunity every Friday — the cadence and structure here are the blueprint for how the $50B nationwide program rolls out.
Read articleSeven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read article